Cetera Investment Advisers
JAZZ icon

Cetera Investment Advisers’s Jazz Pharmaceuticals JAZZ Stock Holding History

Cetera Investment Advisers’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.14M Sell
6,037
-39
-0.6% -$6.82K ﹤0.01% 2794
2025
Q4 		$1.03M Sell
6,076
-2,534
-29% -$388K ﹤0.01% 2788
2025
Q3 		$1.13M Buy
8,610
+1,504
+21% +$180K ﹤0.01% 2670
2025
Q2 		$754K Sell
7,106
-3,430
-33% -$373K ﹤0.01% 2632
2025
Q1 		$1.31M Buy
10,536
+444
+4% +$57.9K ﹤0.01% 2054
2024
Q4 		$1.24M Buy
+10,092
New +$1.19M ﹤0.01% 2017
2024
Q2 		– Sell
-2,460
Closed -$296K – 3803
2024
Q1 		$296K Buy
+2,460
New +$301K ﹤0.01% 3053

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Cetera Investment Advisers's JAZZ Position: Q1 2026 in Review

Cetera Investment Advisers reduced its Jazz Pharmaceuticals (JAZZ) stake by 0.64% in Q1 2026, selling an estimated $6.82K and leaving 6,037 shares worth $1.14M. The position accounts for ﹤0.01% of the portfolio, ranked #2794.

Cetera Investment Advisers first reported a position in JAZZ in Q1 2024 and has held it in 7 quarters since. The position peaked at $1.31M in Q1 2025. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Cetera Investment Advisers held 6,037 shares of Jazz Pharmaceuticals worth $1.14M as of Q1 2026.
  • Cetera Investment Advisers sold 39 Jazz Pharmaceuticals shares in Q1 2026, an estimated $6.82K.
  • Jazz Pharmaceuticals made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q1 2026, its #2794 holding.
  • Cetera Investment Advisers first reported a position in Jazz Pharmaceuticals in Q1 2024 and has held it in 7 quarters since.
  • Cetera Investment Advisers's Jazz Pharmaceuticals position peaked at $1.31M in Q1 2025.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Cetera Investment Advisers's 13F filing for Q1 2026, filed 13 May 2026.